Your browser doesn't support javascript.
loading
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
Wan, Marilyn T; Shin, Daniel B; Winthrop, Kevin L; Gelfand, Joel M.
Afiliación
  • Wan MT; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Shin DB; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Winthrop KL; Division of Infectious Diseases and Public Health, Oregon Health and Sciences University, Portland, Oregon.
  • Gelfand JM; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: joel.gelfand@pennme
J Am Acad Dermatol ; 83(2): 677-679, 2020 08.
Article en En | MEDLINE | ID: mdl-32416207
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Psoriasis / Productos Biológicos / Infecciones por Coronavirus / Interleucina-17 / Toma de Decisiones Clínicas / Betacoronavirus Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Psoriasis / Productos Biológicos / Infecciones por Coronavirus / Interleucina-17 / Toma de Decisiones Clínicas / Betacoronavirus Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article